NASDAQ:SGLB

Sigma Labs Competitors

$3.13

+0.09 (+2.96 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$2.75

Now: $3.13▼

$3.16

50-Day Range

$3.04

MA: $4.11▼

$5.30

52-Week Range

$1.95

Now: $3.13▼

$6.50

Volume175,165 shs

Average Volume499,718 shs

Market Capitalization$24.12 million

P/E RatioN/A

Dividend YieldN/A

Beta1.45

Sigma Labs (NASDAQ:SGLB) Vs. AMCR, ARRY, HI, BRC, DAKT, and CVLB

Should you be buying SGLB stock or one of its competitors? Companies in the industry of "miscellaneous manufacturing industries" are considered alternatives and competitors to Sigma Labs, including Amcor (AMCR), Array Technologies (ARRY), Hillenbrand (HI), Brady (BRC), Daktronics (DAKT), and Conversion Labs (CVLB).

Sigma Labs vs. Amcor Stock

Sigma Labs (NASDAQ:SGLB) and Amcor (NYSE:AMCR) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Sigma Labs and Amcor's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigma Labs	$400,000.00	60.31	$-6,320,000.00	N/A	N/A
Amcor	$12.47 billion	1.45	$612.20 million	$0.64	18.14

Amcor has higher revenue and earnings than Sigma Labs.

Risk & Volatility

Sigma Labs has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Amcor has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.

Profitability

This table compares Sigma Labs and Amcor's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigma Labs	-693.68%	-182.86%	-145.28%
Amcor	6.00%	18.75%	5.57%

Analyst Ratings

This is a summary of current ratings and target prices for Sigma Labs and Amcor, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigma Labs	0	0	1	0	3.00
Amcor	1	8	2	0	2.09

Sigma Labs currently has a consensus price target of $5.00, indicating a potential upside of 59.74%. Amcor has a consensus price target of $12.48, indicating a potential upside of 7.49%. Given Sigma Labs' stronger consensus rating and higher probable upside, analysts plainly believe Sigma Labs is more favorable than Amcor.

Insider & Institutional Ownership

0.9% of Sigma Labs shares are held by institutional investors. Comparatively, 35.0% of Amcor shares are held by institutional investors. 4.6% of Sigma Labs shares are held by insiders. Comparatively, 0.3% of Amcor shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Amcor beats Sigma Labs on 7 of the 12 factors compared between the two stocks.

Sigma Labs vs. Array Technologies Stock

Sigma Labs (NASDAQ:SGLB) and Array Technologies (NASDAQ:ARRY) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Sigma Labs and Array Technologies' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigma Labs	$400,000.00	60.31	$-6,320,000.00	N/A	N/A
Array Technologies	N/A	N/A	N/A	N/A	N/A

Array Technologies has lower revenue, but higher earnings than Sigma Labs.

Profitability

This table compares Sigma Labs and Array Technologies' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigma Labs	-693.68%	-182.86%	-145.28%
Array Technologies	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and target prices for Sigma Labs and Array Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigma Labs	0	0	1	0	3.00
Array Technologies	1	7	5	0	2.31

Sigma Labs currently has a consensus price target of $5.00, indicating a potential upside of 59.74%. Array Technologies has a consensus price target of $49.8750, indicating a potential upside of 45.75%. Given Sigma Labs' stronger consensus rating and higher probable upside, analysts plainly believe Sigma Labs is more favorable than Array Technologies.

Insider & Institutional Ownership

0.9% of Sigma Labs shares are held by institutional investors. 4.6% of Sigma Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Sigma Labs beats Array Technologies on 5 of the 9 factors compared between the two stocks.

Sigma Labs vs. Hillenbrand Stock

Sigma Labs (NASDAQ:SGLB) and Hillenbrand (NYSE:HI) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Sigma Labs and Hillenbrand's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigma Labs	$400,000.00	60.31	$-6,320,000.00	N/A	N/A
Hillenbrand	$2.52 billion	1.49	$-60,100,000.00	$3.19	15.61

Sigma Labs has higher earnings, but lower revenue than Hillenbrand.

Risk & Volatility

Sigma Labs has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Hillenbrand has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.

Profitability

This table compares Sigma Labs and Hillenbrand's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigma Labs	-693.68%	-182.86%	-145.28%
Hillenbrand	-2.39%	18.61%	4.82%

Analyst Ratings

This is a summary of current ratings and target prices for Sigma Labs and Hillenbrand, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigma Labs	0	0	1	0	3.00
Hillenbrand	0	0	2	0	3.00

Sigma Labs currently has a consensus price target of $5.00, indicating a potential upside of 59.74%. Hillenbrand has a consensus price target of $53.00, indicating a potential upside of 6.40%. Given Sigma Labs' higher probable upside, analysts plainly believe Sigma Labs is more favorable than Hillenbrand.

Insider & Institutional Ownership

0.9% of Sigma Labs shares are held by institutional investors. Comparatively, 82.9% of Hillenbrand shares are held by institutional investors. 4.6% of Sigma Labs shares are held by insiders. Comparatively, 3.0% of Hillenbrand shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Hillenbrand beats Sigma Labs on 7 of the 11 factors compared between the two stocks.

Sigma Labs vs. Brady Stock

Sigma Labs (NASDAQ:SGLB) and Brady (NYSE:BRC) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Sigma Labs and Brady's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigma Labs	$400,000.00	60.31	$-6,320,000.00	N/A	N/A
Brady	$1.08 billion	2.62	$112.37 million	$2.11	25.85

Brady has higher revenue and earnings than Sigma Labs.

Risk & Volatility

Sigma Labs has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Brady has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500.

Profitability

This table compares Sigma Labs and Brady's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigma Labs	-693.68%	-182.86%	-145.28%
Brady	10.11%	13.80%	10.22%

Analyst Ratings

This is a summary of current ratings and target prices for Sigma Labs and Brady, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigma Labs	0	0	1	0	3.00
Brady	2	0	2	0	2.00

Sigma Labs currently has a consensus price target of $5.00, indicating a potential upside of 59.74%. Brady has a consensus price target of $50.75, indicating a potential downside of 6.97%. Given Sigma Labs' stronger consensus rating and higher probable upside, analysts plainly believe Sigma Labs is more favorable than Brady.

Insider & Institutional Ownership

0.9% of Sigma Labs shares are held by institutional investors. Comparatively, 74.9% of Brady shares are held by institutional investors. 4.6% of Sigma Labs shares are held by insiders. Comparatively, 15.6% of Brady shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Brady beats Sigma Labs on 8 of the 12 factors compared between the two stocks.

Sigma Labs vs. Daktronics Stock

Sigma Labs (NASDAQ:SGLB) and Daktronics (NASDAQ:DAKT) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Sigma Labs and Daktronics' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigma Labs	$400,000.00	60.31	$-6,320,000.00	N/A	N/A
Daktronics	$608.93 million	0.66	$490,000.00	N/A	N/A

Daktronics has higher revenue and earnings than Sigma Labs.

Risk & Volatility

Sigma Labs has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Daktronics has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.

Profitability

This table compares Sigma Labs and Daktronics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigma Labs	-693.68%	-182.86%	-145.28%
Daktronics	-0.56%	-1.59%	-0.79%

Analyst Ratings

This is a summary of current ratings and target prices for Sigma Labs and Daktronics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigma Labs	0	0	1	0	3.00
Daktronics	0	0	0	0	N/A

Sigma Labs currently has a consensus price target of $5.00, indicating a potential upside of 59.74%. Given Sigma Labs' higher probable upside, analysts plainly believe Sigma Labs is more favorable than Daktronics.

Insider & Institutional Ownership

0.9% of Sigma Labs shares are held by institutional investors. Comparatively, 39.2% of Daktronics shares are held by institutional investors. 4.6% of Sigma Labs shares are held by insiders. Comparatively, 8.3% of Daktronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Daktronics beats Sigma Labs on 7 of the 11 factors compared between the two stocks.

Sigma Labs vs. Conversion Labs Stock

Sigma Labs (NASDAQ:SGLB) and Conversion Labs (NASDAQ:CVLB) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

Earnings & Valuation

This table compares Sigma Labs and Conversion Labs' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sigma Labs	$400,000.00	60.31	$-6,320,000.00	N/A	N/A
Conversion Labs	$12.47 million	29.67	$-3,140,000.00	N/A	N/A

Conversion Labs has higher revenue and earnings than Sigma Labs.

Risk & Volatility

Sigma Labs has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Conversion Labs has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Profitability

This table compares Sigma Labs and Conversion Labs' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sigma Labs	-693.68%	-182.86%	-145.28%
Conversion Labs	-95.36%	N/A	-761.95%

Analyst Ratings

This is a summary of current ratings and target prices for Sigma Labs and Conversion Labs, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sigma Labs	0	0	1	0	3.00
Conversion Labs	0	0	2	0	3.00

Sigma Labs currently has a consensus price target of $5.00, indicating a potential upside of 59.74%. Conversion Labs has a consensus price target of $37.50, indicating a potential upside of 134.96%. Given Conversion Labs' higher probable upside, analysts plainly believe Conversion Labs is more favorable than Sigma Labs.

Insider & Institutional Ownership

0.9% of Sigma Labs shares are held by institutional investors. Comparatively, 0.9% of Conversion Labs shares are held by institutional investors. 4.6% of Sigma Labs shares are held by insiders. Comparatively, 27.9% of Conversion Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Conversion Labs beats Sigma Labs on 7 of the 11 factors compared between the two stocks.